← Alle mensen

GA

Gursel Aktan

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endom...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 januari 2025
Totale overleving with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer.
The New England journal of medicine · 28 november 2024
Pembrolizumab bij vroeg TNBC: KEYNOTE-522 event-vrije overleving update
The New England journal of medicine · 10 februari 2022
Pembrolizumab plus chemotherapie versus placebo plus chemotherapie bij vroeg TNBC: KEYNOTE-522 event-vrije overleving
Lancet (London, England) · 5 december 2020
Pembrolizumab bij vroeg triple-negatief mammacarcinoom: KEYNOTE-522 fase III
The New England journal of medicine · 27 februari 2020